Hazardous drug handling NIOSH Table 2 drugs

PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.

2 posts / 0 new

Last post

Wed, 04/04/2018 - 09:04

Jane Mauro

Offline

Last seen: 5 years 8 months ago

Joined: 07/07/2017 - 19:18

Hazardous drug handling NIOSH Table 2 drugs

Hi all,

I know this question has been asked in various forms many times, but I couldn't find exactly the answer I was looking for.

For the NIOSH Table 2 drugs that just have possible carcinogenicity (IARC 2B, NTP***, or lab animal carcinogenicity) like spironolactone, divalproex, risperidone, etc, is that handled as regular medication or hazardous? In my AoR I have those meds as hazardous if being handled by someone at risk of reproductive hazard, but handled as regular medications if personnel is not at risk of hazard. Just wondering if this is going to be a problem for when our TJC survey rolls around. Thank you ahead of time for your responses!

Jane

Members Log In